Skip to main content
Industry News
Disease burden higher with treatment-resistant HIV
10/16/2020

Patients whose HIV is resistant to four classes of drugs experience a greater rate of malignancies and higher burden of disease, according to a study published in the journal Open Forum Infectious Diseases. The rate of clinical events or mortality with four-class drug-resistant HIV was 25% over four years.

Full Story: